Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification.

Annual review of medicine - 1 Jan 2016

Komanduri Krishna V, Levine Ross L

Abstract excerpt

The diagnosis and risk stratification of acute myeloid leukemia (AML) primarily rely on morphologic analysis and assessment of karyotype by chromosome banding analysis. For decades, standard AML induction therapy has utilized the combination of anthracyclines and cytarabine. Despite the use of postremission therapy, less than half of patients with AML will be cured of their disease. Allogeneic hematopoietic stem...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Chromosome Aberrations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Immunotherapy

Share to Induction Chemotherapy

Share to Leukemia, Myeloid, Acute

Share to Prognosis

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 26473413
DOI: 10.1146/annurev-med-051914-021329
PMCID: PMC5701748

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification.PMID 26473413Read ↗

Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic Insights.Semantic proximity Read ↗

Unified classification and risk-stratification in Acute Myeloid LeukemiaSemantic proximity Read ↗

Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapiesSemantic proximity Read ↗

Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.Semantic proximity Read ↗

Advances in acute myeloid leukemia.Semantic proximity Read ↗

Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.Semantic proximity Read ↗

Classification and risk assessment in AML: integrating cytogenetics and molecular profilingSemantic proximity Read ↗

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?Semantic proximity Read ↗

Advances in therapeutic options for newly diagnosed, high-risk AML patientsSemantic proximity Read ↗

Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.Semantic proximity Read ↗

Advances in Diagnosis and Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes.Semantic proximity Read ↗

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.